Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients ; volume:22 ; number:1 ; day:15 ; month:4 ; year:2020 ; pages:1-9 ; date:12.2020
Arthritis Research & Therapy ; 22, Heft 1 (15.4.2020), 1-9, 12.2020
- Urheber
-
Campanilho-Marques, Raquel
Deakin, Claire T.
Simou, Stefania
Papadopoulou, Charalampia
Wedderburn, Lucy R.
Pilkington, Clarissa A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-020-02164-5
- URN
-
urn:nbn:de:101:1-2020062815024703116802
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Campanilho-Marques, Raquel
- Deakin, Claire T.
- Simou, Stefania
- Papadopoulou, Charalampia
- Wedderburn, Lucy R.
- Pilkington, Clarissa A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Juvenile Dermatomyositis
Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial
Juvenile Dermatomyositis – Kombinationstherapie überlegen
Juvenile Dermatomyositis—Clinical Phenotypes
Dyslipidemia in Juvenile Dermatomyositis
Cardiac evaluation of patients with juvenile dermatomyositis
Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients
Dyslipidemia in active juvenile dermatomyositis patients
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis
Juvenile idiopathische Arthritis – Adalimumab – sicher und effizient
Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis
Juvenile Dermatomyositis
Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial
Juvenile Dermatomyositis – Kombinationstherapie überlegen
Juvenile Dermatomyositis—Clinical Phenotypes
Dyslipidemia in Juvenile Dermatomyositis
Cardiac evaluation of patients with juvenile dermatomyositis
Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients
Dyslipidemia in active juvenile dermatomyositis patients
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis
Juvenile idiopathische Arthritis – Adalimumab – sicher und effizient
Potential association of LMNA-associated generalized lipodystrophy with juvenile dermatomyositis
Juvenile Dermatomyositis
Local injection of infliximab into calcinosis lesions in patients with juvenile dermatomyositis (JDM): a clinical trial
Juvenile Dermatomyositis – Kombinationstherapie überlegen
Juvenile Dermatomyositis—Clinical Phenotypes
Dyslipidemia in Juvenile Dermatomyositis
Cardiac evaluation of patients with juvenile dermatomyositis
Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients
Dyslipidemia in active juvenile dermatomyositis patients
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis
Juvenile idiopathische Arthritis – Adalimumab – sicher und effizient